NCT05973409

Brief Summary

This study is being conducted to determine if scleral lenses treated with Hydra-PEG improve comfort and dryness.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 26, 2022

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

March 23, 2023

Completed
4 months until next milestone

First Posted

Study publicly available on registry

August 2, 2023

Completed
13 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2023

Completed
Last Updated

April 17, 2026

Status Verified

April 1, 2026

Enrollment Period

11 months

First QC Date

March 23, 2023

Last Update Submit

April 14, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • overall ocular comfort

    reported at the screening visit for the habitual vision correction, and at the 4-week follow-up visits for each of the two study lenses. using a 0-10 scale (0.5 steps)

    4 weeks

Study Arms (2)

Habitual Soft Lens Wearers

EXPERIMENTAL

Each group will be a prospective, randomized, double masked, cross-over, 1-month per arm, daily wear study. Each participant will be active in the study for at least 2 months.

Device: scleral lens

Non Contact Lens Wearers

EXPERIMENTAL

Each group will be a prospective, randomized, double masked, cross-over, 1-month per arm, daily wear study. Each participant will be active in the study for at least 2 months.

Device: scleral lens

Interventions

scleral lens with and without hydra-peg treatment

Habitual Soft Lens WearersNon Contact Lens Wearers

Eligibility Criteria

Age17 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Are at least 17 years of age and have full legal capacity to volunteer;
  • Have read and signed an information consent letter;
  • Are willing and able to follow instructions and maintain the appointment schedule;
  • Agree to wear the study scleral lenses for at least 8 hours per day, 5 days a week;
  • Have a refraction between +20.00 and -20.00D and spectacle astigmatism of no more than -3.00DC in each eye;
  • Have best corrected visual acuity of 20/40 or better in each eye with the study lenses;
  • Demonstrate an acceptable fit with the study lenses;
  • Have no active ocular disease or inflammation;
  • Group 1: Habitual wearer of frequent replacement or daily disposable soft lenses;
  • Group 2: Have not worn contact lenses for 6 months;
  • Group 1: Contact lens wearers should score ≥12 on CLDEQ-8;
  • Group 2: Non contact lens wearers should score ≥13 on OSDI.

You may not qualify if:

  • Are participating in any concurrent clinical or research study, or have done so within the past 30 days;
  • Cannot achieve a successful lens fit or vision with the study lens;
  • Have been diagnosed with keratoconus or corneal distortion;
  • Have any known active\* ocular condition, disease and/or infection;
  • Have a systemic or ocular condition that in the opinion of the investigator may affect a study outcome variable e.g. pingueculae;
  • Are using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable;
  • Group 2: Non-contact lens wearers who score ≥33 on OSDI and also demonstrate either corneal staining ≥3 (Oxford scale) or non-invasive tear break-up time ≤3 seconds#;
  • Have known sensitivity to the diagnostic sodium fluorescein to be used in the study;
  • Are pregnant, lactating or planning a pregnancy\^ at the time of enrolment, by self report;
  • Have undergone refractive error surgery;
  • Are listed on the Delegation Log for this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

School of Optometry & Vision Sciences

Waterloo, Ontario, N2L 3G1, Canada

Location

MeSH Terms

Conditions

Dry Eye Syndromes

Condition Hierarchy (Ancestors)

Lacrimal Apparatus DiseasesEye Diseases

Study Officials

  • Lyndon Jones, PhD

    Director, Centre for Ocular Research and Education

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
At the fitting visit, only uncoated lenses will be used to determine the parameters of the lenses to be ordered. At both dispense visits, participants and investigators will be masked to the lens type dispensed. In order to achieve this, unmasked study personnel will determine the order of lens wear according to the randomization schedule and they will not share the lens labels or packs with the investigator. Instead, the lenses will be transferred to an unmarked case/container prior to being provided at the Dispense visit.
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 23, 2023

First Posted

August 2, 2023

Study Start

September 26, 2022

Primary Completion

August 15, 2023

Study Completion

August 15, 2023

Last Updated

April 17, 2026

Record last verified: 2026-04

Locations